Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Differences in abuse potential of ADHD drugs measured by contrasting poison centre and therapeutic use data

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Potential pharmacobezoar formation of large size extended-release tablets and their dissolution - an in vitro study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Utilization of lipid emulsion therapy in fatal overdose cases: an observational study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Recreational drug use at a major music festival: trend analysis of anonymised pooled urine

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Somatiske årsager til akut opståede psykiatriske tilstande hos børn og unge

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. High-Dose Glucagon Has Hemodynamic Effects Regardless of Cardiac Beta-Adrenoceptor Blockade: A Randomized Clinical Trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Active chlordiazepoxide metabolites in a patient needing life support after treatment of alcohol abstinence

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Reappraisal is an effective emotion regulation strategy in children with Tourette syndrome and ADHD

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Access and Use of Device-Aided Therapies for Parkinson's Disease in Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

CONTEXT: Atomoxetine (ATX) is the treatment of choice for attention deficit hyperactivity disorders with co-morbid risk of drug abuse, although its abuse potential needs to be qualified. The purpose of this study is to analyse ATX misuse in relation to therapeutic use and compare our results with that of methylphenidate (MPH).

METHODS AND MATERIALS: Data on enquiries were extracted from the Danish Poison Information Centre database (January 2006 to June 2012), while data on therapeutic use were provided by the Danish State Serum Institute (2007-2011).

RESULTS: The study included 28 ATX and 394 MPH enquiries. Frequency of ATX enquiries did not show a significant correlation to either sale or number of treated patients but for MPH, both correlations were significant (p = 0.001 and p = 0.0008, respectively). The enquiries/number of treated patients relationship differed significantly between ATX and MPH (p = 0.018), but not the enquiries/sale relationship. The proportion of exposures motivated by recreational drug use was significantly lower for ATX (19%) than that for MPH (40%) (p = 0.038).

DISCUSSION AND CONCLUSION: These results suggest that ATX is used by adults for non-medical purposes including recreational use, but to a lesser extent than MPH.

Original languageEnglish
JournalClinical toxicology (Philadelphia, Pa.)
Volume53
Issue number4
Pages (from-to)210-4
Number of pages5
ISSN1556-3650
DOIs
Publication statusPublished - May 2015

ID: 45330412